Parkinson’s disease falls among the most mysterious and health-threatening disorders of the day. Affecting over 10 million people worldwide, scientists struggled with finding the cure for Parkinson’s disease for decades back…until now.
A new-found therapy now faces the dangers of Parkinson’s disease, promising a silent triumph over this disease.
The Pill That Treats Parkinson’s Disease
Parkinson’s disease is a condition affecting the nervous system, causing severe tremors in the body tissues. However, the revolutionary new therapy presented by the University of Queensland, and supported by the Michael J. Fox Foundation, launched a new pill which will prevent the loss of brain cells in patients with Parkinson’s disease.
The group managed to discover ‘a key underlying driver for the disease’ which will hopefully lead to successful therapy for Parkinson’s disease. The therapeutic pill in question is considered an effective tool against the disease due to a molecule in it, called MCC950. This very compound was a subject of research a few years back, but was dismissed as an ineffective treatment. Now, the same molecule is making a comeback and facing the dangers of Parkinson’s disease with success.
The molecule found in the pill, showed a reduction in brain inflammation, which then diminishes the progress of the disease itself. If taken daily, the pill can largely suppress symptoms of Parkinson’s disease and help patients retrieve their natural body motion.
How Does the Pill Prevent Parkinson’s?
As per Dr. Woodruff, Parkinson’s disease prevents the brain to increase the production of dopamine. Dopamine is a body chemical in charge of controlling our body motions. When dopamine is found in small levels in the body, it can lead to other problems, like chronic inflammation, immunity crash, and brain damage. Dr. Woodruff and his team also found that in Parkinson’s patients, the body produces more NLRP3, an inflammasome which is found in both our blood and brain.
However, the team found that when patients orally received the molecule MCC950 once a day, it ‘blocked NLRP3 activation in the brain and prevented the loss of brain cells, resulting in markedly improved motor function.’
Once the discovery was made, the use of MCC950 escalated. At the same time, the Michael J. Fox Foundation for Parkinson’s Research and Inflazome expects to conduct more trials testing the molecule and medically determining its benefits in the fight against Parkinson’s.
A Glance into the Future
Parkinson’s disease has affected millions of lives across the globe, giving patients little hope in ever treating Parkinson’s disease. Fortunately, this new medical breakthrough is set out to amend the existing medical indications on how to treat Parkinson’s disease. As a result, scientists are introducing a new pace in the race against this sneaky condition, giving patients a glance of what the future without Parkinson’s may look like.